DAIHAN Scientific Statistics
Total Valuation
DAIHAN Scientific has a market cap or net worth of KRW 34.02 billion. The enterprise value is 37.92 billion.
Market Cap | 34.02B |
Enterprise Value | 37.92B |
Important Dates
The last earnings date was Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
DAIHAN Scientific has 7.45 million shares outstanding. The number of shares has decreased by -1.12% in one year.
Current Share Class | n/a |
Shares Outstanding | 7.45M |
Shares Change (YoY) | -1.12% |
Shares Change (QoQ) | -6.91% |
Owned by Insiders (%) | 34.43% |
Owned by Institutions (%) | n/a |
Float | 4.40M |
Valuation Ratios
The trailing PE ratio is 12.54.
PE Ratio | 12.54 |
Forward PE | n/a |
PS Ratio | 0.45 |
PB Ratio | 0.86 |
P/TBV Ratio | n/a |
P/FCF Ratio | 12.43 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.12, with an EV/FCF ratio of 13.85.
EV / Earnings | 14.80 |
EV / Sales | 0.54 |
EV / EBITDA | 6.12 |
EV / EBIT | 8.70 |
EV / FCF | 13.85 |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.04.
Current Ratio | 3.59 |
Quick Ratio | 1.19 |
Debt / Equity | 0.04 |
Debt / EBITDA | 0.34 |
Debt / FCF | 0.77 |
Interest Coverage | 28.69 |
Financial Efficiency
Return on equity (ROE) is 8.00% and return on invested capital (ROIC) is 5.35%.
Return on Equity (ROE) | 8.00% |
Return on Assets (ROA) | 4.34% |
Return on Capital (ROIC) | 5.35% |
Revenue Per Employee | 614.22M |
Profits Per Employee | 22.28M |
Employee Count | 115 |
Asset Turnover | 1.13 |
Inventory Turnover | 1.90 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.76% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -23.76% |
50-Day Moving Average | 4,845.90 |
200-Day Moving Average | 5,538.93 |
Relative Strength Index (RSI) | 34.80 |
Average Volume (20 Days) | 14,318 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DAIHAN Scientific had revenue of KRW 70.64 billion and earned 2.56 billion in profits. Earnings per share was 363.90.
Revenue | 70.64B |
Gross Profit | 20.42B |
Operating Income | 4.34B |
Pretax Income | 4.61B |
Net Income | 2.56B |
EBITDA | 6.18B |
EBIT | 4.34B |
Earnings Per Share (EPS) | 363.90 |
Balance Sheet
The company has 8.12 billion in cash and 2.11 billion in debt, giving a net cash position of 6.01 billion or 805.92 per share.
Cash & Cash Equivalents | 8.12B |
Total Debt | 2.11B |
Net Cash | 6.01B |
Net Cash Per Share | 805.92 |
Equity (Book Value) | 49.29B |
Book Value Per Share | 5,284.70 |
Working Capital | 30.80B |
Cash Flow
In the last 12 months, operating cash flow was 3.25 billion and capital expenditures -507.80 million, giving a free cash flow of 2.74 billion.
Operating Cash Flow | 3.25B |
Capital Expenditures | -507.80M |
Free Cash Flow | 2.74B |
FCF Per Share | 367.33 |
Margins
Gross margin is 28.92%, with operating and profit margins of 6.15% and 3.63%.
Gross Margin | 28.92% |
Operating Margin | 6.15% |
Pretax Margin | 6.53% |
Profit Margin | 3.63% |
EBITDA Margin | 8.75% |
EBIT Margin | 6.15% |
FCF Margin | 3.88% |
Dividends & Yields
This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 1.30%.
Dividend Per Share | 60.00 |
Dividend Yield | 1.30% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 27.03% |
Buyback Yield | 1.12% |
Shareholder Yield | 2.42% |
Earnings Yield | 7.97% |
FCF Yield | 8.05% |
Stock Splits
The last stock split was on December 29, 2014. It was a forward split with a ratio of 1.07.
Last Split Date | Dec 29, 2014 |
Split Type | Forward |
Split Ratio | 1.07 |
Scores
DAIHAN Scientific has an Altman Z-Score of 4.74.
Altman Z-Score | 4.74 |
Piotroski F-Score | n/a |